Baptist Health Hospital in Madisonville has been approved to use a clinical trial using plasma from recovered COVID-19 patients as a potential treatment option for those severely suffering with COVID-19.
According to a news release, the plasma treatment allows current COVID-19 patients to receive plasma from recovered patients. The study is being spearheaded locally by Dr. Stacey Miller as Principle Investigator and Dr. Kevin Williams as Sub-Principle Investigator through the Baptist Health Clinical Research Center. Convalescent plasma contains antibodies believed to fight the COVID-19 virus that may help patients improve more quickly.
To donate, recovered COVID-19 patients are encouraged to visit where information about plasma donation can be found on the Western Kentucky Regional Blood Center site.
People who have fully recovered from COVID-19 may qualify to donate plasma if they meet specific plasma and blood donation eligibility requirements including, a COVID-19 diagnosis confirmed by a laboratory test, have fully recovered from COVID-19 for 14-days and are 18 years old weighing at least 110 pounds.